Background: Though primarily a pulmonary disease, Coronavirus disease 2019 (COVID-19)
caused by the SARS-CoV-2 virus can generate devastating disease states that affect …

Pulmonary thromboembolic events have been linked to coronavirus disease 2019 (COVID‐
19), but their incidence and long‐term sequelae remain unclear. We performed a systematic …

Background The COVID-19 pandemic disproportionately affected minorities in population
rates of infection, hospitalization, and mortality. However, little is known about the broader …

Importance COVID-19 has disproportionately affected racialized populations, with particular
impact among individuals of Black individuals. However, it is unclear whether disparities in …

Abstract Objective Coronavirus disease 2019 (COVID-19) is associated with an increased
risk of venous thromboembolism (VTE). Recent studies have characterized racial disparities …

Materials and Methods This was a retrospective, cross-sectional study of 208 hospitalized
COVID-19 patients who received a computed tomographic pulmonary angiography (CTPA) …

The COVID-19 pandemic, by the nature of this crisis and its primarily sanitary, medical and
biological management, offers an exceptional opportunity for observations on the scientific …

Objectives Studies have shown that coronavirus disease 2019 (COVID-19) is associated
with a hypercoagulable state. Studies have yet to examine the interconnectedness between …

Background COVID‐19 associated coagulopathy (CAC) can either be localized or systemic
hypercoagulable state with increased risk of thromboembolism. This study looked into the …

Access to neurologic care and neuroscience research is often limited by social determinants
of health (SDoH), such as race, ethnicity, socioeconomic status, and education. These …